Chunky deals1 Oct 2025 18:59
Tim mentioned they are looking at chunky deals
"Chunky deals" in the pharmaceutical industry refer to large-scale mergers and acquisitions (M&A) where companies buy or combine with other entities to acquire new technologies, drugs, or market share. These are strategic, high-value transactions, such as Pfizer's potential $7.3 billion purchase of obesity drug developer Metsera or Novartis's up to $3.1 billion acquisition of cardiovascular-focused Anthos Therapeutics.
Examples of "chunky deals":
Pfizer's acquisition of Metsera:
A potential $7.3 billion deal to acquire Metsera, a biotech firm focusing on obesity.
Novartis's acquisition of Anthos Therapeutics:
Novartis is set to acquire Anthos for up to $3.1 billion to bolster its cardiovascular pipeline.
Merck KGaA's acquisition of SpringWorks Therapeutics:
A $3.9 billion deal to enhance its rare cancer therapies.
Jazz Pharmaceuticals' acquisition of Chimerix:
A $935 million investment to grow its oncology portfolio.
AstraZeneca's acquisition of Alexion:
A $39 billion acquisition in 2020, which was a major move to expand into rare diseases.